Chronic Kidney Disease

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Fresh pooled data in JAMA strengthen calls to make SGLT2 inhibitors standard care across the CKD spectrum.